Future Fields is pleased to announce the performance results of their first human growth factor, Recombinant Human FGF2.
World First: Human Growth Factor Made From Fruit Flies for Life Science Applications Shows High Performance
New B7 Family Immune Checkpoint Proteins
Recently 5 new B7 family ligands, B7-H3, B7-H4, B7-H5, B7-H6 & B7-H7, were identified, all of them possibly of high interest in immunotherapy research.
HVEM – BTLA – LIGHT – CD160 Network
The checkpoint receptors/ligands system HVEM, LIGHT, CD160 and BTLA (CD272) is part of a complex network of overlapping receptor interactions.
TIGIT – CD155 – CD112 – CD226 Network
Tumour cells exploit the dominance of the inhibitory TIGIT pathway to avoid immune-mediated destruction.
LAG-3 – Major Histocompatibility Complex (MHC) – T Cell Receptor (TCR) Pathway
Dual inhibition of LAG-3 and other checkpoint pathways may synergistically increase T cell antitumour activity.
CTLA-4 [CD152] – CD80 – CD86 – CD28 Network
![CTLA-4 [CD152] – CD80 – CD86 – CD28 Network](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/cd28-600x300.png "CTLA-4 [CD152] – CD80 – CD86 – CD28 Network")
Targeting CTLA-4 restores immune response by more accumulation, function & survival of T cells, depletion of Tregs & better antitumour response.
CD40 – CD40L Pathway
CD40 is a member of the TNF receptor family expressed by APCs and B cells whereas its ligand, CD40L (CD154), is expressed by activated T cells.
GITR – GITRL Pathway
Glucocorticoid-induced TNFR-related protein is an activating receptor on the surface of T cells and other immune cells, binding to its ligand GITRL.
CD137 – CD137L Pathway
CD137 is an activating receptor binding to CD137L, expressed on natural killer (NK) cells & T cells, therefore triggering innate & adaptive immunity.
TIM-3 – Galectin-9 Pathway
T cell immunoglobulin & mucin-3 (TIM-3; HAVcr-2) is an immune checkpoint receptor involved in the suppression of both innate & adaptive immune cells.